AU9311398A - Stable anhydrous formulation - Google Patents

Stable anhydrous formulation

Info

Publication number
AU9311398A
AU9311398A AU93113/98A AU9311398A AU9311398A AU 9311398 A AU9311398 A AU 9311398A AU 93113/98 A AU93113/98 A AU 93113/98A AU 9311398 A AU9311398 A AU 9311398A AU 9311398 A AU9311398 A AU 9311398A
Authority
AU
Australia
Prior art keywords
stable anhydrous
anhydrous formulation
formulation
stable
anhydrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU93113/98A
Other languages
English (en)
Inventor
Andrew J. Bevacqua
Gheorghe Cioca
Konstantinos M. Lahanas
Daniela Toma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EL Management LLC
Original Assignee
EL Management LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EL Management LLC filed Critical EL Management LLC
Publication of AU9311398A publication Critical patent/AU9311398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU93113/98A 1997-09-16 1998-09-10 Stable anhydrous formulation Abandoned AU9311398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93157297A 1997-09-16 1997-09-16
US08931572 1997-09-16
PCT/US1998/018804 WO1999013859A1 (fr) 1997-09-16 1998-09-10 Formulation anhydre stable

Publications (1)

Publication Number Publication Date
AU9311398A true AU9311398A (en) 1999-04-05

Family

ID=25460997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU93113/98A Abandoned AU9311398A (en) 1997-09-16 1998-09-10 Stable anhydrous formulation

Country Status (6)

Country Link
EP (1) EP0952818A1 (fr)
JP (1) JP2001505227A (fr)
KR (1) KR20000068995A (fr)
AU (1) AU9311398A (fr)
CA (1) CA2270073A1 (fr)
WO (1) WO1999013859A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228894B1 (en) 1998-04-17 2001-05-08 Enhanced Derm Technologies, Inc. Softgel-compatible composition containing retinol
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6039935A (en) * 1998-12-30 2000-03-21 Elizabeth Arden Company, Division Of Conopco, Inc. Sunscreen compositions
DE19962369A1 (de) * 1999-12-23 2001-06-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee und einem weiteren Gehalt an Ascorbinsäure
ATE311847T1 (de) 2000-07-10 2005-12-15 Procter & Gamble Kosmetische zusammensetzungen
KR100479665B1 (ko) * 2002-04-03 2005-03-30 주식회사 나우코스 현미, 녹차, 포공영에 유효 미생물을 접종하여 발효시켜얻은 항산화력이 증진된 화장료 조성물
EP1543821B1 (fr) * 2002-07-25 2008-02-13 Lion Corporation Preparations externes
KR100879133B1 (ko) * 2002-12-23 2009-01-19 주식회사 엘지생활건강 비수유화 미백 화장료 조성물 및 그의 제조방법
KR20040067710A (ko) * 2003-01-24 2004-07-30 주식회사 엘지생활건강 비수유화 주름개선용 화장료 조성물
JP5199231B2 (ja) 2006-03-21 2013-05-15 ダウ・コーニング・コーポレイション シリコーンポリエーテルエラストマーゲル
EP2001933B9 (fr) 2006-03-21 2016-02-17 Dow Corning Corporation Gels d'elastomere de polyether de silicone
JP2010540721A (ja) 2007-09-26 2010-12-24 ダウ・コーニング・コーポレイション オルガノポリシロキサン樹脂からのシリコーン有機エラストマーゲル
US20110306721A1 (en) * 2010-06-10 2011-12-15 Veerag Mehta Flame retardant material having enhanced pull through lubricity
WO2012016652A1 (fr) 2010-08-04 2012-02-09 Services Petroliers Schlumberger Système de mesure de débit et procédé de mesure d'une quantité de liquide dans un écoulement polyphasique principalement gazeux
US20140219934A1 (en) * 2013-02-01 2014-08-07 Sandra Senzon Botanical tooth whitener composition and method for treating discolored or stained teeth
US9132080B2 (en) * 2013-03-21 2015-09-15 Julius Zecchino Delivery system having stabilized ascorbic acid and other actives
US20140348873A1 (en) * 2013-05-22 2014-11-27 Professional Compounding Centers Of America Urea-Silicone Gel for Hyperkeratosis Treatment
US20140350106A1 (en) * 2013-05-22 2014-11-27 Professional Compounding Centers Of America Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729850A1 (fr) * 1995-01-30 1996-08-02 Oreal Composition cosmetique comprenant un compose silicone et un ester d'acide gras
FR2732595A1 (fr) * 1995-04-07 1996-10-11 Oreal Utilisation de polymeres pour reduire l'effet irritant des actifs dans une composition cosmetique et/ou dermatologique
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
FR2744911B1 (fr) * 1996-02-19 1998-03-20 Oreal Utilisation d'un organopolysiloxane solide elastomere associe a une phase grasse pour la preparation d'une composition ou dans une composition de soin ou de maquillage pour matifier la peau
US5833973A (en) * 1996-06-28 1998-11-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Crosslinked elastomeric silicones in aqueous emulsion cosmetic compositions
ZA971943B (en) * 1996-06-28 1998-09-07 Unilever Plc Vitamin C delivery system
FR2757380B1 (fr) * 1996-12-24 1999-01-29 Oreal Composition de maquillage ou de soin, sans transfert, contenant un organopolysiloxane et une phase grasse

Also Published As

Publication number Publication date
CA2270073A1 (fr) 1999-03-25
JP2001505227A (ja) 2001-04-17
WO1999013859A1 (fr) 1999-03-25
EP0952818A1 (fr) 1999-11-03
KR20000068995A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
AU8551198A (en) Agrochemical formulation
EP0926468B8 (fr) Dispositif d'affichage
AU6513298A (en) Therapeutic compositions
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
ZA9811461B (en) New formulation
AU9311398A (en) Stable anhydrous formulation
AU7964398A (en) Dental formulation
AU6508898A (en) Improved display
AU1559199A (en) Isothiazolcarboxylic acid derivatives
HK1026429A1 (en) New formulation
GB9724544D0 (en) Novel Formulation
GB9709739D0 (en) Pharmaceutical formulation
GB9725061D0 (en) Revitalisation formulation
GB9706957D0 (en) Formulation
GB9810180D0 (en) Novel formulation
AU5182099A (en) Pharmaceutical formulation
AU4795497A (en) Anthelmintic formulation
AU1649700A (en) Novel formulation
AU8012898A (en) Formulations containing surfactants
AU4567997A (en) Formulations containing phosphatidylethanolamine
AU8079198A (en) Pesticide formulation
AU3194197A (en) Stainblocking agent
AUPO511297A0 (en) Radiolabelled formulation
AU3934597A (en) Sustained peptide-release formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase